APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Grade Glycine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Grade Glycine Market Outlook and Growth Opportunities 2026

Report ID 173328020410 April 2026Not stated

Choose your research edition.

Industry ResearchPharmaceutical Grade Glycine Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Grade Glycine Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Grade Glycine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Grade Glycine Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Grade Glycine Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Pharmaceutical Grade Glycine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical Grade Glycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Grade Glycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Grade Glycine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical Grade Glycine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical Grade Glycine market include Yuki Gosei Kogyo, WEGO, Showa Denko KK, Shijiazhuang Haitian Amino acid, Shijiazhuang Donghua Jinlong Chemical, Paras Intermediates Private Limited, Linxi Hongtai, Kyowa and Hubei Xingfa Chemicals Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pharmaceutical Grade Glycine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical Grade Glycine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Grade Glycine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pharmaceutical Grade Glycine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pharmaceutical Grade Glycine Segment by Company

Yuki Gosei Kogyo

WEGO

Showa Denko KK

Shijiazhuang Haitian Amino acid

Shijiazhuang Donghua Jinlong Chemical

Paras Intermediates Private Limited

Linxi Hongtai

Kyowa

Hubei Xingfa Chemicals Group

Hebei Donghuajian Chemicals

Hebei Donghua Jiheng Chemical

GEO Specialty Chemicals

FabriChem

Evonik

CJ CheilJedang

Chattem Chemicals

AMINO GmbH

Amino GmbH

Ajinomoto

Pharmaceutical Grade Glycine Segment by Type

>98%

>99%

Pharmaceutical Grade Glycine Segment by Application

Hospital

Clinic

Other

Pharmaceutical Grade Glycine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Grade Glycine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pharmaceutical Grade Glycine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Grade Glycine significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Grade Glycine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Grade Glycine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Grade Glycine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Grade Glycine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharmaceutical Grade Glycine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Grade Glycine industry.

Chapter 3: Detailed analysis of Pharmaceutical Grade Glycine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pharmaceutical Grade Glycine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pharmaceutical Grade Glycine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Grade Glycine Industry Trends Table 2. Pharmaceutical Grade Glycine Industry Drivers Table 3. Pharmaceutical Grade Glycine Industry Opportunities and Challenges Table 4. Pharmaceutical Grade Glycine Industry Restraints Table 5. Global Pharmaceutical Grade Glycine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Grade Glycine Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Grade Glycine Sales Volume by Company (kt) & (2021-2026) Table 8. Global Pharmaceutical Grade Glycine Sales Volume Share by Company (2021-2026) Table 9. Global Pharmaceutical Grade Glycine Average Price (USD/t) of Company (2021-2026) Table 10. Global Pharmaceutical Grade Glycine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pharmaceutical Grade Glycine Key Company Manufacturing Base & Headquarters Table 12. Global Pharmaceutical Grade Glycine Company, Product Type & Application Table 13. Global Pharmaceutical Grade Glycine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pharmaceutical Grade Glycine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of >98% Table 18. Significant Companies of >99% Table 19. Global Pharmaceutical Grade Glycine Sales Volume by Type 2021 VS 2025 VS 2032 (kt) Table 20. Global Pharmaceutical Grade Glycine Sales Volume by Type (2021-2026) & (kt) Table 21. Global Pharmaceutical Grade Glycine Sales Volume by Type (2027-2032) & (kt) Table 22. Global Pharmaceutical Grade Glycine Sales Volume Share by Type (2021-2026) Table 23. Global Pharmaceutical Grade Glycine Sales Volume Share by Type (2027-2032) Table 24. Global Pharmaceutical Grade Glycine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical Grade Glycine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical Grade Glycine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical Grade Glycine Sales Value Share by Type (2021-2026) Table 28. Global Pharmaceutical Grade Glycine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Pharmaceutical Grade Glycine Sales Volume by Application 2021 VS 2025 VS 2032 (kt) Table 33. Global Pharmaceutical Grade Glycine Sales Volume by Application (2021-2026) & (kt) Table 34. Global Pharmaceutical Grade Glycine Sales Volume by Application (2027-2032) & (kt) Table 35. Global Pharmaceutical Grade Glycine Sales Volume Share by Application (2021-2026) Table 36. Global Pharmaceutical Grade Glycine Sales Volume Share by Application (2027-2032) Table 37. Global Pharmaceutical Grade Glycine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Pharmaceutical Grade Glycine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Pharmaceutical Grade Glycine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical Grade Glycine Sales Value Share by Application (2021-2026) Table 41. Global Pharmaceutical Grade Glycine Sales Value Share by Application (2027-2032) Table 42. Global Pharmaceutical Grade Glycine Sales by Region: 2021 VS 2025 VS 2032 (kt) Table 43. Global Pharmaceutical Grade Glycine Sales by Region (2021-2026) & (kt) Table 44. Global Pharmaceutical Grade Glycine Sales Market Share by Region (2021-2026) Table 45. Global Pharmaceutical Grade Glycine Sales by Region (2027-2032) & (kt) Table 46. Global Pharmaceutical Grade Glycine Sales Market Share by Region (2027-2032) Table 47. Global Pharmaceutical Grade Glycine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Pharmaceutical Grade Glycine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Pharmaceutical Grade Glycine Sales Value Share by Region (2021-2026) Table 50. Global Pharmaceutical Grade Glycine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Pharmaceutical Grade Glycine Sales Value Share by Region (2027-2032) Table 52. Global Pharmaceutical Grade Glycine Market Average Price (USD/t) by Region (2021-2026) Table 53. Global Pharmaceutical Grade Glycine Market Average Price (USD/t) by Region (2027-2032) Table 54. Global Pharmaceutical Grade Glycine Sales by Country: 2021 VS 2025 VS 2032 (kt) Table 55. Global Pharmaceutical Grade Glycine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Pharmaceutical Grade Glycine Sales by Country (2021-2026) & (kt) Table 57. Global Pharmaceutical Grade Glycine Sales Market Share by Country (2021-2026) Table 58. Global Pharmaceutical Grade Glycine Sales by Country (2027-2032) & (kt) Table 59. Global Pharmaceutical Grade Glycine Sales Market Share by Country (2027-2032) Table 60. Global Pharmaceutical Grade Glycine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Pharmaceutical Grade Glycine Sales Value Market Share by Country (2021-2026) Table 62. Global Pharmaceutical Grade Glycine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Pharmaceutical Grade Glycine Sales Value Market Share by Country (2027-2032) Table 64. Yuki Gosei Kogyo Company Information Table 65. Yuki Gosei Kogyo Business Overview Table 66. Yuki Gosei Kogyo Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 67. Yuki Gosei Kogyo Pharmaceutical Grade Glycine Product Portfolio Table 68. Yuki Gosei Kogyo Recent Development Table 69. WEGO Company Information Table 70. WEGO Business Overview Table 71. WEGO Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. WEGO Pharmaceutical Grade Glycine Product Portfolio Table 73. WEGO Recent Development Table 74. Showa Denko KK Company Information Table 75. Showa Denko KK Business Overview Table 76. Showa Denko KK Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Showa Denko KK Pharmaceutical Grade Glycine Product Portfolio Table 78. Showa Denko KK Recent Development Table 79. Shijiazhuang Haitian Amino acid Company Information Table 80. Shijiazhuang Haitian Amino acid Business Overview Table 81. Shijiazhuang Haitian Amino acid Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Shijiazhuang Haitian Amino acid Pharmaceutical Grade Glycine Product Portfolio Table 83. Shijiazhuang Haitian Amino acid Recent Development Table 84. Shijiazhuang Donghua Jinlong Chemical Company Information Table 85. Shijiazhuang Donghua Jinlong Chemical Business Overview Table 86. Shijiazhuang Donghua Jinlong Chemical Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Shijiazhuang Donghua Jinlong Chemical Pharmaceutical Grade Glycine Product Portfolio Table 88. Shijiazhuang Donghua Jinlong Chemical Recent Development Table 89. Paras Intermediates Private Limited Company Information Table 90. Paras Intermediates Private Limited Business Overview Table 91. Paras Intermediates Private Limited Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Paras Intermediates Private Limited Pharmaceutical Grade Glycine Product Portfolio Table 93. Paras Intermediates Private Limited Recent Development Table 94. Linxi Hongtai Company Information Table 95. Linxi Hongtai Business Overview Table 96. Linxi Hongtai Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Linxi Hongtai Pharmaceutical Grade Glycine Product Portfolio Table 98. Linxi Hongtai Recent Development Table 99. Kyowa Company Information Table 100. Kyowa Business Overview Table 101. Kyowa Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. Kyowa Pharmaceutical Grade Glycine Product Portfolio Table 103. Kyowa Recent Development Table 104. Hubei Xingfa Chemicals Group Company Information Table 105. Hubei Xingfa Chemicals Group Business Overview Table 106. Hubei Xingfa Chemicals Group Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Hubei Xingfa Chemicals Group Pharmaceutical Grade Glycine Product Portfolio Table 108. Hubei Xingfa Chemicals Group Recent Development Table 109. Hebei Donghuajian Chemicals Company Information Table 110. Hebei Donghuajian Chemicals Business Overview Table 111. Hebei Donghuajian Chemicals Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Hebei Donghuajian Chemicals Pharmaceutical Grade Glycine Product Portfolio Table 113. Hebei Donghuajian Chemicals Recent Development Table 114. Hebei Donghua Jiheng Chemical Company Information Table 115. Hebei Donghua Jiheng Chemical Business Overview Table 116. Hebei Donghua Jiheng Chemical Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 117. Hebei Donghua Jiheng Chemical Pharmaceutical Grade Glycine Product Portfolio Table 118. Hebei Donghua Jiheng Chemical Recent Development Table 119. GEO Specialty Chemicals Company Information Table 120. GEO Specialty Chemicals Business Overview Table 121. GEO Specialty Chemicals Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 122. GEO Specialty Chemicals Pharmaceutical Grade Glycine Product Portfolio Table 123. GEO Specialty Chemicals Recent Development Table 124. FabriChem Company Information Table 125. FabriChem Business Overview Table 126. FabriChem Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 127. FabriChem Pharmaceutical Grade Glycine Product Portfolio Table 128. FabriChem Recent Development Table 129. Evonik Company Information Table 130. Evonik Business Overview Table 131. Evonik Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 132. Evonik Pharmaceutical Grade Glycine Product Portfolio Table 133. Evonik Recent Development Table 134. CJ CheilJedang Company Information Table 135. CJ CheilJedang Business Overview Table 136. CJ CheilJedang Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 137. CJ CheilJedang Pharmaceutical Grade Glycine Product Portfolio Table 138. CJ CheilJedang Recent Development Table 139. Chattem Chemicals Company Information Table 140. Chattem Chemicals Business Overview Table 141. Chattem Chemicals Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 142. Chattem Chemicals Pharmaceutical Grade Glycine Product Portfolio Table 143. Chattem Chemicals Recent Development Table 144. AMINO GmbH Company Information Table 145. AMINO GmbH Business Overview Table 146. AMINO GmbH Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 147. AMINO GmbH Pharmaceutical Grade Glycine Product Portfolio Table 148. AMINO GmbH Recent Development Table 149. Amino GmbH Company Information Table 150. Amino GmbH Business Overview Table 151. Amino GmbH Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 152. Amino GmbH Pharmaceutical Grade Glycine Product Portfolio Table 153. Amino GmbH Recent Development Table 154. Ajinomoto Company Information Table 155. Ajinomoto Business Overview Table 156. Ajinomoto Pharmaceutical Grade Glycine Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 157. Ajinomoto Pharmaceutical Grade Glycine Product Portfolio Table 158. Ajinomoto Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Pharmaceutical Grade Glycine Distributors List Table 162. Pharmaceutical Grade Glycine Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Pharmaceutical Grade Glycine Product Image Figure 2. Global Pharmaceutical Grade Glycine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Grade Glycine Sales (2021-2032) & (kt) Figure 5. Global Pharmaceutical Grade Glycine Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Pharmaceutical Grade Glycine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. >98% Image Figure 10. >99% Image Figure 11. Global Pharmaceutical Grade Glycine Sales Volume by Type (2021 VS 2025 VS 2032) & (kt) Figure 12. Global Pharmaceutical Grade Glycine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Grade Glycine Sales Volume Share by Type (2021-2032) Figure 14. Global Pharmaceutical Grade Glycine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pharmaceutical Grade Glycine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pharmaceutical Grade Glycine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Pharmaceutical Grade Glycine Sales Volume by Application (2021 VS 2025 VS 2032) & (kt) Figure 21. Global Pharmaceutical Grade Glycine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Pharmaceutical Grade Glycine Sales Volume Share by Application (2021-2032) Figure 23. Global Pharmaceutical Grade Glycine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Pharmaceutical Grade Glycine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Pharmaceutical Grade Glycine Sales Value Share by Application (2021-2032) Figure 26. Global Pharmaceutical Grade Glycine Sales by Region: 2021 VS 2025 VS 2032 (kt) Figure 27. Global Pharmaceutical Grade Glycine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Pharmaceutical Grade Glycine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Pharmaceutical Grade Glycine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Pharmaceutical Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Pharmaceutical Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Pharmaceutical Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Pharmaceutical Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Pharmaceutical Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Pharmaceutical Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Pharmaceutical Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Pharmaceutical Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Pharmaceutical Grade Glycine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Pharmaceutical Grade Glycine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Pharmaceutical Grade Glycine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Pharmaceutical Grade Glycine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • >98%
  • >99%
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yuki Gosei Kogyo
  • WEGO
  • Showa Denko KK
  • Shijiazhuang Haitian Amino acid
  • Shijiazhuang Donghua Jinlong Chemical
  • Paras Intermediates Private Limited
  • Linxi Hongtai
  • Kyowa
  • Hubei Xingfa Chemicals Group
  • Hebei Donghuajian Chemicals
  • Hebei Donghua Jiheng Chemical
  • GEO Specialty Chemicals
  • FabriChem
  • Evonik
  • CJ CheilJedang
  • Chattem Chemicals
  • AMINO GmbH
  • Amino GmbH
  • Ajinomoto

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pharmaceutical Grade Glycine Sales Value (2021-2032)
  4. 1.2.2 Global Pharmaceutical Grade Glycine Sales Volume (2021-2032)
  5. 1.2.3 Global Pharmaceutical Grade Glycine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pharmaceutical Grade Glycine Market Dynamics
  1. 2.1 Pharmaceutical Grade Glycine Industry Trends
  2. 2.2 Pharmaceutical Grade Glycine Industry Drivers
  3. 2.3 Pharmaceutical Grade Glycine Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Grade Glycine Industry Restraints
3 Pharmaceutical Grade Glycine Market by Company
  1. 3.1 Global Pharmaceutical Grade Glycine Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Grade Glycine Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Grade Glycine Sales Volume by Company (2021-2026)
  4. 3.4 Global Pharmaceutical Grade Glycine Average Price by Company (2021-2026)
  5. 3.5 Global Pharmaceutical Grade Glycine Company Ranking (2024-2026)
  6. 3.6 Global Pharmaceutical Grade Glycine Company Manufacturing Base and Headquarters
  7. 3.7 Global Pharmaceutical Grade Glycine Company Product Type and Application
  8. 3.8 Global Pharmaceutical Grade Glycine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pharmaceutical Grade Glycine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pharmaceutical Grade Glycine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pharmaceutical Grade Glycine Market by Type
  1. 4.1 Pharmaceutical Grade Glycine Type Introduction
  2. 4.1.1 >98%
  3. 4.1.2 >99%
  4. 4.2 Global Pharmaceutical Grade Glycine Sales Volume by Type
  5. 4.2.1 Global Pharmaceutical Grade Glycine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical Grade Glycine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical Grade Glycine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pharmaceutical Grade Glycine Sales Value by Type
  9. 4.3.1 Global Pharmaceutical Grade Glycine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pharmaceutical Grade Glycine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pharmaceutical Grade Glycine Sales Value Share by Type (2021-2032)
5 Pharmaceutical Grade Glycine Market by Application
  1. 5.1 Pharmaceutical Grade Glycine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Pharmaceutical Grade Glycine Sales Volume by Application
  6. 5.2.1 Global Pharmaceutical Grade Glycine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical Grade Glycine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical Grade Glycine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Pharmaceutical Grade Glycine Sales Value by Application
  10. 5.3.1 Global Pharmaceutical Grade Glycine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pharmaceutical Grade Glycine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Pharmaceutical Grade Glycine Sales Value Share by Application (2021-2032)
6 Pharmaceutical Grade Glycine Regional Sales and Value Analysis
  1. 6.1 Global Pharmaceutical Grade Glycine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Grade Glycine Sales by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Grade Glycine Sales by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Grade Glycine Sales by Region (2027-2032)
  5. 6.3 Global Pharmaceutical Grade Glycine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pharmaceutical Grade Glycine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pharmaceutical Grade Glycine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pharmaceutical Grade Glycine Sales Value by Region (2027-2032)
  9. 6.5 Global Pharmaceutical Grade Glycine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pharmaceutical Grade Glycine Sales Value (2021-2032)
  12. 6.6.2 North America Pharmaceutical Grade Glycine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pharmaceutical Grade Glycine Sales Value (2021-2032)
  15. 6.7.2 Europe Pharmaceutical Grade Glycine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pharmaceutical Grade Glycine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pharmaceutical Grade Glycine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pharmaceutical Grade Glycine Sales Value (2021-2032)
  21. 6.9.2 South America Pharmaceutical Grade Glycine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pharmaceutical Grade Glycine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pharmaceutical Grade Glycine Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Grade Glycine Country-level Sales and Value Analysis
  1. 7.1 Global Pharmaceutical Grade Glycine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Grade Glycine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pharmaceutical Grade Glycine Sales by Country (2021-2032)
  4. 7.3.1 Global Pharmaceutical Grade Glycine Sales by Country (2021-2026)
  5. 7.3.2 Global Pharmaceutical Grade Glycine Sales by Country (2027-2032)
  6. 7.4 Global Pharmaceutical Grade Glycine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pharmaceutical Grade Glycine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pharmaceutical Grade Glycine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pharmaceutical Grade Glycine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pharmaceutical Grade Glycine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pharmaceutical Grade Glycine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yuki Gosei Kogyo
  2. 8.1.1 Yuki Gosei Kogyo Company Information
  3. 8.1.2 Yuki Gosei Kogyo Business Overview
  4. 8.1.3 Yuki Gosei Kogyo Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yuki Gosei Kogyo Pharmaceutical Grade Glycine Product Portfolio
  6. 8.1.5 Yuki Gosei Kogyo Recent Developments
  7. 8.2 WEGO
  8. 8.2.1 WEGO Company Information
  9. 8.2.2 WEGO Business Overview
  10. 8.2.3 WEGO Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 WEGO Pharmaceutical Grade Glycine Product Portfolio
  12. 8.2.5 WEGO Recent Developments
  13. 8.3 Showa Denko KK
  14. 8.3.1 Showa Denko KK Company Information
  15. 8.3.2 Showa Denko KK Business Overview
  16. 8.3.3 Showa Denko KK Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Showa Denko KK Pharmaceutical Grade Glycine Product Portfolio
  18. 8.3.5 Showa Denko KK Recent Developments
  19. 8.4 Shijiazhuang Haitian Amino acid
  20. 8.4.1 Shijiazhuang Haitian Amino acid Company Information
  21. 8.4.2 Shijiazhuang Haitian Amino acid Business Overview
  22. 8.4.3 Shijiazhuang Haitian Amino acid Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shijiazhuang Haitian Amino acid Pharmaceutical Grade Glycine Product Portfolio
  24. 8.4.5 Shijiazhuang Haitian Amino acid Recent Developments
  25. 8.5 Shijiazhuang Donghua Jinlong Chemical
  26. 8.5.1 Shijiazhuang Donghua Jinlong Chemical Company Information
  27. 8.5.2 Shijiazhuang Donghua Jinlong Chemical Business Overview
  28. 8.5.3 Shijiazhuang Donghua Jinlong Chemical Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shijiazhuang Donghua Jinlong Chemical Pharmaceutical Grade Glycine Product Portfolio
  30. 8.5.5 Shijiazhuang Donghua Jinlong Chemical Recent Developments
  31. 8.6 Paras Intermediates Private Limited
  32. 8.6.1 Paras Intermediates Private Limited Company Information
  33. 8.6.2 Paras Intermediates Private Limited Business Overview
  34. 8.6.3 Paras Intermediates Private Limited Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Paras Intermediates Private Limited Pharmaceutical Grade Glycine Product Portfolio
  36. 8.6.5 Paras Intermediates Private Limited Recent Developments
  37. 8.7 Linxi Hongtai
  38. 8.7.1 Linxi Hongtai Company Information
  39. 8.7.2 Linxi Hongtai Business Overview
  40. 8.7.3 Linxi Hongtai Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Linxi Hongtai Pharmaceutical Grade Glycine Product Portfolio
  42. 8.7.5 Linxi Hongtai Recent Developments
  43. 8.8 Kyowa
  44. 8.8.1 Kyowa Company Information
  45. 8.8.2 Kyowa Business Overview
  46. 8.8.3 Kyowa Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kyowa Pharmaceutical Grade Glycine Product Portfolio
  48. 8.8.5 Kyowa Recent Developments
  49. 8.9 Hubei Xingfa Chemicals Group
  50. 8.9.1 Hubei Xingfa Chemicals Group Company Information
  51. 8.9.2 Hubei Xingfa Chemicals Group Business Overview
  52. 8.9.3 Hubei Xingfa Chemicals Group Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hubei Xingfa Chemicals Group Pharmaceutical Grade Glycine Product Portfolio
  54. 8.9.5 Hubei Xingfa Chemicals Group Recent Developments
  55. 8.10 Hebei Donghuajian Chemicals
  56. 8.10.1 Hebei Donghuajian Chemicals Company Information
  57. 8.10.2 Hebei Donghuajian Chemicals Business Overview
  58. 8.10.3 Hebei Donghuajian Chemicals Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hebei Donghuajian Chemicals Pharmaceutical Grade Glycine Product Portfolio
  60. 8.10.5 Hebei Donghuajian Chemicals Recent Developments
  61. 8.11 Hebei Donghua Jiheng Chemical
  62. 8.11.1 Hebei Donghua Jiheng Chemical Company Information
  63. 8.11.2 Hebei Donghua Jiheng Chemical Business Overview
  64. 8.11.3 Hebei Donghua Jiheng Chemical Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Hebei Donghua Jiheng Chemical Pharmaceutical Grade Glycine Product Portfolio
  66. 8.11.5 Hebei Donghua Jiheng Chemical Recent Developments
  67. 8.12 GEO Specialty Chemicals
  68. 8.12.1 GEO Specialty Chemicals Company Information
  69. 8.12.2 GEO Specialty Chemicals Business Overview
  70. 8.12.3 GEO Specialty Chemicals Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 GEO Specialty Chemicals Pharmaceutical Grade Glycine Product Portfolio
  72. 8.12.5 GEO Specialty Chemicals Recent Developments
  73. 8.13 FabriChem
  74. 8.13.1 FabriChem Company Information
  75. 8.13.2 FabriChem Business Overview
  76. 8.13.3 FabriChem Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 FabriChem Pharmaceutical Grade Glycine Product Portfolio
  78. 8.13.5 FabriChem Recent Developments
  79. 8.14 Evonik
  80. 8.14.1 Evonik Company Information
  81. 8.14.2 Evonik Business Overview
  82. 8.14.3 Evonik Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Evonik Pharmaceutical Grade Glycine Product Portfolio
  84. 8.14.5 Evonik Recent Developments
  85. 8.15 CJ CheilJedang
  86. 8.15.1 CJ CheilJedang Company Information
  87. 8.15.2 CJ CheilJedang Business Overview
  88. 8.15.3 CJ CheilJedang Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CJ CheilJedang Pharmaceutical Grade Glycine Product Portfolio
  90. 8.15.5 CJ CheilJedang Recent Developments
  91. 8.16 Chattem Chemicals
  92. 8.16.1 Chattem Chemicals Company Information
  93. 8.16.2 Chattem Chemicals Business Overview
  94. 8.16.3 Chattem Chemicals Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Chattem Chemicals Pharmaceutical Grade Glycine Product Portfolio
  96. 8.16.5 Chattem Chemicals Recent Developments
  97. 8.17 AMINO GmbH
  98. 8.17.1 AMINO GmbH Company Information
  99. 8.17.2 AMINO GmbH Business Overview
  100. 8.17.3 AMINO GmbH Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 AMINO GmbH Pharmaceutical Grade Glycine Product Portfolio
  102. 8.17.5 AMINO GmbH Recent Developments
  103. 8.18 Amino GmbH
  104. 8.18.1 Amino GmbH Company Information
  105. 8.18.2 Amino GmbH Business Overview
  106. 8.18.3 Amino GmbH Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Amino GmbH Pharmaceutical Grade Glycine Product Portfolio
  108. 8.18.5 Amino GmbH Recent Developments
  109. 8.19 Ajinomoto
  110. 8.19.1 Ajinomoto Company Information
  111. 8.19.2 Ajinomoto Business Overview
  112. 8.19.3 Ajinomoto Pharmaceutical Grade Glycine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Ajinomoto Pharmaceutical Grade Glycine Product Portfolio
  114. 8.19.5 Ajinomoto Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pharmaceutical Grade Glycine Value Chain Analysis
  2. 9.1.1 Pharmaceutical Grade Glycine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pharmaceutical Grade Glycine Sales Mode & Process
  6. 9.2 Pharmaceutical Grade Glycine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pharmaceutical Grade Glycine Distributors
  9. 9.2.3 Pharmaceutical Grade Glycine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst